{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:11:10Z","timestamp":1780726270707,"version":"3.54.1"},"reference-count":58,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Purpose: This study assessed the inter- and intra-fractional dosimetric impact of MR-Linac-based adaptive radiotherapy for cervical cancer (CC).\nMethods: A retrospective analysis of five node-negative, locally advanced cervical cancer patients treated under the MOMENTUM study (NCT04075305) using adapt-to-shape (ATS) on an Elekta Unity MR-Linac. Assessing the dosimetric impact of daily online adaptations: (1) comparing dose between daily adapted (MR-adapted) and non-adapted (MR-guided) plans, by quantifying dose differences relative to reference plans (by 2 and 5%) and evaluating adaptation frequency; (2) performing intra-fraction dose evaluations. Dose metrics for targets and organs at risk (OARs) were evaluated following EMBRACE II guidelines.\nResults: MR-adapted plans improved target coverage or reduced OAR dose in 82\u2013100% of fractions at a 2% dose deviation (and in 25\u201384% at a 5% deviation), compared to MR-guided plans. Dose reductions for OARs ranged from 2 to 8% for D0.1%, 4.77\u201316.70% for V4000cGy and 2.10\u201314.00% for V3000cGy. Intra-fraction analysis showed that the difference between daily planned and delivered doses in all target structures was not clinically significant, ranging from 0.08 to 2.20%, except two fractions that experienced higher deviations (5%) in ITV45. Treatment was well-tolerated, with no Grade 2 or 3 toxicities reported.\nInterpretation: MR-guided plans required adaptation in 25\u2013100% of the fractions when compared to MR-adapted plans. MR-adapted plans demonstrated enhanced target dose consistency and reduced OAR dose for all patients, highlighting the benefits of daily adaptation. Despite longer treatment times, dose accuracy was preserved. Toxicity results for MRgART in CC appear promising.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.42898","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T01:24:43Z","timestamp":1747704283000},"page":"693-702","source":"Crossref","is-referenced-by-count":3,"title":["Quantifying the dosimetric impact of online daily adaptation for MR-guided RT in cervical cancer"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8004-5238","authenticated-orcid":false,"given":"Amerah","family":"Alshamrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-5120","authenticated-orcid":false,"given":"Robert","family":"Chuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6452-0310","authenticated-orcid":false,"given":"Marianne","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-9567","authenticated-orcid":false,"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2340-7773","authenticated-orcid":false,"given":"Claire","family":"Nelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-6580","authenticated-orcid":false,"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-3582","authenticated-orcid":false,"given":"Lisa","family":"Barraclough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5445-5428","authenticated-orcid":false,"given":"Cynthia L.","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"112310","doi-asserted-by":"crossref","unstructured":"Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys. 2013;87:542\u20138.","DOI":"10.1016\/j.ijrobp.2013.06.2059"},{"key":"112311","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/J.IJROBP.2013.06.2059","DOI":"10.1016\/j.ijrobp.2013.06.2059"},{"key":"112312","doi-asserted-by":"crossref","unstructured":"Naik A, Gurjar OP, Gupta KL, Singh K, Nag P, Bhandari V. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: a randomized prospective study. Cancer\/Radioth\u00e9rapie. 2016;20:370\u20136.","DOI":"10.1016\/j.canrad.2016.05.011"},{"key":"112313","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/J.CANRAD.2016.05.011","DOI":"10.1016\/j.canrad.2016.05.011"},{"key":"112314","doi-asserted-by":"crossref","unstructured":"Ahmad R, Hoogeman MS, Bondar M, Dhawtal V, Quint S, De Pree I, et al. Increasing treatment accuracy for cervical cancer patients using correlations between bladder-filling change and cervix-uterus displacements: proof of principle. Radiother Oncol. 2011;98:340\u20136.","DOI":"10.1016\/j.radonc.2010.11.010"},{"key":"112315","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2010.11.010","DOI":"10.1016\/j.radonc.2010.11.010"},{"key":"112316","doi-asserted-by":"crossref","unstructured":"Walsh L, Morgia M, Fyles A, Milosevic M. Technological advances in radiotherapy for cervical cancer. Curr Opin Oncol. 2011;23:512\u20138.","DOI":"10.1097\/CCO.0b013e3283499d93"},{"key":"112317","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/CCO.0b013e3283499d93","DOI":"10.1097\/CCO.0b013e3283499d93"},{"key":"112318","doi-asserted-by":"crossref","unstructured":"Tyagi N, Lewis JH, Yashar CM, Vo D, Jiang SB, Mundt AJ, et al. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer. Int J Radiat Oncol Biol Phys. 2011;80:273\u201380.","DOI":"10.1016\/j.ijrobp.2010.06.003"},{"key":"112319","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.003","DOI":"10.1016\/j.ijrobp.2010.06.003"},{"key":"112320","doi-asserted-by":"crossref","unstructured":"Jadon R, Pembroke CA, Hanna CL, Palaniappan N, Evans M, Cleves AE, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol. 2014;26:185\u201396.","DOI":"10.1016\/j.clon.2013.11.031"},{"key":"112321","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.clon.2013.11.031","DOI":"10.1016\/j.clon.2013.11.031"},{"key":"112322","unstructured":"On Target 2: Updated guidance for image-guided radiotherapy [Internet]. London: The Royal College of Radiologists; 2021 [cited 2024 Dec 15]. Available from: https:\/\/www.rcr.ac.uk\/our-services\/all-our-publications\/clinical-oncology-publications\/on-target-2-updated-guidance-for-image-guided-radiotherapy\/"},{"key":"112323","doi-asserted-by":"crossref","unstructured":"Winkel D, Bol GH, Kroon PS, van Asselen B, Hackett SS, Werensteijn-Honingh AM, et al. Adaptive radiotherapy: the Elekta Unity MR-linac concept. Clin Transl Radiat Oncol. 2019;18:54\u20139.","DOI":"10.1016\/j.ctro.2019.04.001"},{"key":"112324","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ctro.2019.04.001","DOI":"10.1016\/j.ctro.2019.04.001"},{"key":"112325","doi-asserted-by":"crossref","unstructured":"Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, et al. Clinical implementation and initial experience with a 1.5 Tesla MR-Linac for MR-guided radiation therapy for gynecologic cancer: an R-IDEAL stage 1 and 2a first in humans feasibility study of new technology implementation. Pract Radiat Oncol. 2022;12:e296\u2013305.","DOI":"10.1016\/j.prro.2022.03.002"},{"key":"112326","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/J.PRRO.2022.03.002","DOI":"10.1016\/j.prro.2022.03.002"},{"key":"112327","doi-asserted-by":"crossref","unstructured":"Ding S, Liu H, Wang B, Li Y, Liu B, Ouyang Y, et al. Inter- and intrafraction bladder and rectum motion in patients with cervical cancer under MR-guided radiotherapy on a 1.5T MR-Linac. Int J Radiat Oncol Biol Phys. 2021;111:e612.","DOI":"10.1016\/j.ijrobp.2021.07.1630"},{"key":"112328","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.07.1630","DOI":"10.1016\/j.ijrobp.2021.07.1630"},{"key":"112329","doi-asserted-by":"crossref","unstructured":"Li JY, Ouyang Y, Cao X. First postoperative cervical cancer patients treated with a 1.5 unity MR-Linac and analysis of treatment safety and acute toxicity. Int J Radiat Oncol Biol Phys. 2020;108:e485.","DOI":"10.1016\/j.ijrobp.2020.07.1542"},{"key":"112330","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.07.1542","DOI":"10.1016\/j.ijrobp.2020.07.1542"},{"key":"112331","doi-asserted-by":"crossref","unstructured":"Chang ATY, Yang B, Wong JT. 2644: clinical experience of adaptive radiotherapy using MR-Linac or tomotherapy for gynecological cancers. Radiother Oncol. 2024;194:S1095\u20137.","DOI":"10.1016\/S0167-8140(24)02817-2"},{"key":"112332","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0167-8140(24)02817-2","DOI":"10.1016\/S0167-8140(24)02817-2"},{"key":"112333","unstructured":"The MOMENTUM Study: the multiple outcome evaluation of radiation therapy using the MR-Linac study \u2013 full text view. ClinicalTrials.gov; n.d. [cited 2024 Feb 26]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04075305"},{"key":"112334","doi-asserted-by":"crossref","unstructured":"de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, et al. The MOMENTUM study: an international registry for the evidence-based introduction of MR-guided adaptive therapy. Front Oncol. 2020;10:1328.","DOI":"10.3389\/fonc.2020.01328"},{"key":"112335","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fonc.2020.01328","DOI":"10.3389\/fonc.2020.01328"},{"key":"112336","unstructured":"Tanderup K, P\u00f6tter R, Lindegaard J, Kirisits C, Juergenliemk-Schulz I, de Leeuw A, et al. Image guided intensity modulated External beam radiochemotherapy and MRI based adaptive Brachytherapy in locally advanced Cervical cancer. EMBRACE II Protocol; 2019 [Internet]. [cited in 2024 Dec 13] Available from: https:\/\/www.embracestudy.dk\/UserUpload\/PublicDocuments\/EMBRACE%20II%20Protocol.pdf"},{"key":"112337","doi-asserted-by":"crossref","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48\u201360.","DOI":"10.1016\/j.ctro.2018.01.001"},{"key":"112338","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ctro.2018.01.001","DOI":"10.1016\/j.ctro.2018.01.001"},{"key":"112339","doi-asserted-by":"crossref","unstructured":"Jadon R, Higgins E, Hanna L, Evans M, Coles B, Staffurth J. A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy. Radiat Oncol. 2019;14:57.","DOI":"10.1186\/s13014-019-1262-8"},{"key":"112340","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s13014-019-1262-8","DOI":"10.1186\/s13014-019-1262-8"},{"key":"112341","doi-asserted-by":"crossref","unstructured":"Chang AT, Tan LT, Ng DS. Challenges for quality assurance of target volume delineation in clinical trials. Clin Trials Front Oncol. 2017;7:221.","DOI":"10.3389\/fonc.2017.00221"},{"key":"112342","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3389\/fonc.2017.00221","DOI":"10.3389\/fonc.2017.00221"},{"key":"112343","doi-asserted-by":"crossref","unstructured":"Davison M, Kim D, Keller H. Radiotherapy dose fractionation under parameter uncertainty. AIP Conf Proc. 2011;1368:179\u201382.","DOI":"10.1063\/1.3663489"},{"key":"112344","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1063\/1.3663489","DOI":"10.1063\/1.3663489"},{"key":"112345","doi-asserted-by":"crossref","unstructured":"Scaife JE, Bs MB, Barnett GC, Noble DJ, Bchir MB, Jena R, et al. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015;88(1051):20150172.","DOI":"10.1259\/bjr.20150172"},{"key":"112346","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1259\/bjr.20150172","DOI":"10.1259\/bjr.20150172"},{"key":"112347","doi-asserted-by":"crossref","unstructured":"Bolt M, Clark CH, Nisbet A, Chen T. Quantification of the uncertainties within the radiotherapy dosimetry chain and their impact on tumour control. Phys Imaging Radiat Oncol. 2021;19:33-38.","DOI":"10.1016\/j.phro.2021.06.004"},{"key":"112348","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.phro.2021.06.004","DOI":"10.1016\/j.phro.2021.06.004"},{"key":"112349","doi-asserted-by":"crossref","unstructured":"Ahmad R, Bondar L, Voet P, Mens J-W, Quint S, Dhawtal G, et al. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: a dosimetric evaluation. Acta Oncologica. Acta Oncol. 2013; 52(7):1430-1436.","DOI":"10.3109\/0284186X.2013.813640"},{"key":"112350","unstructured":"https:\/\/doi.org\/10.3109\/028"},{"key":"112351","doi-asserted-by":"crossref","unstructured":"Rigaud B, Simon A, Gobeli M, Lafond C, Leseur J, Barateau A, et al. CBCT-guided evolutive library for cervical adaptive IMRT. Med Phys. 2018;45:1379\u201390.","DOI":"10.1002\/mp.12818"},{"key":"112352","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/mp.12818","DOI":"10.1002\/mp.12818"},{"key":"112353","doi-asserted-by":"crossref","unstructured":"Bondar ML, Hoogeman MS, Mens JW, Quint S, Ahmad R, Dhawtal G, et al. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Int J Radiat Oncol Biol Phys. 2012;83:1617\u201323.","DOI":"10.1016\/j.ijrobp.2011.10.011"},{"key":"112354","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.011","DOI":"10.1016\/j.ijrobp.2011.10.011"},{"key":"112355","doi-asserted-by":"crossref","unstructured":"Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, et al. Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: an R-IDEAL stage 1\/2a first in humans\/feasibility study of new technology implementation. MedRxiv. 2021;12(4):e296-e305.","DOI":"10.1016\/j.prro.2022.03.002"},{"key":"112356","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1101\/2021.12.03.21266962","DOI":"10.1101\/2021.12.03.21266962"},{"key":"112357","doi-asserted-by":"crossref","unstructured":"Nachbar M, lo Russo M, Gani C, Boeke S, Wegener D, Paulsen F, et al. Automatic AI-based contouring of prostate MRI for online adaptive radiotherapy. Z Med Phys. 2024;34:197\u2013207.","DOI":"10.1016\/j.zemedi.2023.05.001"},{"key":"112358","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/J.ZEMEDI.2023.05.001","DOI":"10.1016\/j.zemedi.2023.05.001"},{"key":"112359","doi-asserted-by":"crossref","unstructured":"Hu Y, Nguyen H, Smith C, Chen T, Byrne M, Archibald-Heeren B, et al. Clinical assessment of a novel machine-learning automated contouring tool for radiotherapy planning. J Appl Clin Med Phys. 2023 Jul;24(7):e13949.","DOI":"10.1002\/acm2.13949"},{"key":"112360","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/acm2.13949","DOI":"10.1002\/acm2.13949"},{"key":"112361","doi-asserted-by":"crossref","unstructured":"Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, et al. Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG Oncology RTOG 1203 Study. J Clin Oncol. 2020;38:1685\u201392.","DOI":"10.1200\/JCO.19.02381"},{"key":"112362","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.19.02381","DOI":"10.1200\/JCO.19.02381"},{"key":"112363","doi-asserted-by":"crossref","unstructured":"Gikandi A, Hallet J, Koerkamp BG, Clark CJ, Lillemoe KD, Narayan RR, et al. Distinguishing clinical from statistical significances in contemporary comparative effectiveness research. Ann Surg. 2024;279:907\u201312.","DOI":"10.1097\/SLA.0000000000006250"},{"key":"112364","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/SLA.0000000000006250","DOI":"10.1097\/SLA.0000000000006250"},{"key":"112365","unstructured":"[PDF] Common pitfalls in statistical analysis: clinical versus statistical significance. Semantic Scholar; n.d. [cited 2024 Sep 24]. Available from: https:\/\/www.semanticscholar.org\/paper\/Common-pitfalls-in-statistical-analysis%3A-Clinical-Ranganathan-Pramesh\/4a58cb30f7c1ce4bc78769a6cfad26e4a62e83e9"},{"key":"112366","doi-asserted-by":"crossref","unstructured":"Alshamrani A, Aznar M, Hoskin P, Chuter R, Eccles CL. The current use of adaptive strategies for external beam radiotherapy in cervical cancer: a systematic review. Clin Oncol. 2024;36(12):e483-e493.","DOI":"10.1016\/j.clon.2024.09.005"},{"key":"112367","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/J.CLON.2024.09.005","DOI":"10.1016\/j.clon.2024.09.005"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/42898\/50182","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/42898\/50182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:29Z","timestamp":1756404269000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/42898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.42898","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}